Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19389820 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed PUMP STUDY MDI Lantus/Lispro vs Continuous Insulin+Lispro
Condition: Diabetes Mellitus
Intervention: Drug: Insulin Glargine

Indicates status has not been verified in more than two years